期刊文献+

曲安奈德与雷珠单抗治疗黄斑水肿的效果比较 被引量:2

Comparaison of the efficacy between subtenon injection of triamcinolone acetonide and intravitreal injection of ranibizumab for macular edema
原文传递
导出
摘要 目的比较曲安奈德与雷珠单抗治疗视网膜静脉分支阻塞继发黄斑水肿的效果.方法回顾性病例研究.分析郑州市第七人民医院2016年6月至2018年6月视网膜静脉分支静脉继发黄斑水肿60例(60眼)患者的临床资料.所有患者分为曲安奈德组和雷珠单抗组,每组各30例.分别进行曲安奈德后部眼球筋膜下注射和雷珠单抗玻璃体内注射.随访6个月比较两组的效果.结果两组治疗后1、2、3和6个月最佳矫正视力较治疗前提高(P<0.05),但两组之间差异无统计学意义.两组注药后黄斑中心区厚度均较治疗前有明显降低(P<0.05),两组之间差异无统计学意义(P>0.05).结论曲安奈德后部眼球筋膜下注射治疗BRVO继发黄斑水肿效果与雷珠单抗玻璃体内注射效果相同,但注射方法较为简单安全. Objective To compare the efficacy between subtenon injection of triamcinolone acetonide and intravitreal injection of ranibizumab in the treatment of macular edema secondary to branch retinal vein occlusion(BRVO).Methods This was a retrospective case study.The clinical data of 60 eyes of 60 patients from Jun.2016 to Jun.2018 in the Seventh People’s Hospital of Zhengzhou were analyzed.All cases were divided into two groups,30 patients in each group.Group A received subtenon injection of triamcinolone acetonide and group B received intravitreal injection of ranibizumab.The efficacy was compared between the two groups.The follow-up time was 6 months.Results BCVA of two groups were improved at 1,2,3 and 6 months after injection(P<0.05).But the difference was not statistically significant between the two groups.The central macular thickness after injection decreased significantly in two groups(P<0.05),and there was no significant difference between the two groups.Conclusion The efficacy of subtenon injection of triamcinolone acetonide for macular edema secondary to BRVO is the same as the intravitreal injection of ranibizumab,but the former injection method is simple and safe.
作者 许路加 刘德成 杨倩倩 王彦 杨红伟 郭春峰 Xu Lujia;Liu Decheng;Yang Qianqian;Wang Yan;Yang Hongwei;Guo Chunfeng(Department of Ophthalmology,The Seventh People’s Hospital of Zhengzhou,Zhengzhou 450006,China;Kaifeng Guangming Hospital of Zhengzhou,Kaifeng 475000,China)
出处 《中华眼外伤职业眼病杂志》 2020年第9期704-708,共5页 Chinese Journal of Ocular Trauma and Occupational Eye Disease
关键词 水肿 黄斑 阻塞 静脉 分支 视网膜 曲安奈德 注射 眼球筋膜下 雷珠单抗 注射 玻璃体内 Edema,macula Ocolusion,vein,branch,retina Triamcinolone acetonide,injection,subfascial capsule of eyeball Ranibizumab,injection,intravitreal
  • 相关文献

参考文献6

二级参考文献14

  • 1Guex-Crosier Y. The pathogenesis and clinical presentation of macular edema in inflammatory diseases[J].{H}DOCUMENTA OPHTHALMOLOGICA,1999.297-309. 被引量:1
  • 2Wroblewski JJ,Wells JA 3 rd,Adamis AP. Pegaptanib sodium for macular edema secondary to central retinal vein occlusion[J].{H}Archives of Ophthalmology,2009.374-380. 被引量:1
  • 3Campochiaro PA,Brown DM,Awh CC. Sustained benefits from ranibizumab for macular edema following central retinal vein Occlusion:twelve-month outcomes of a phase Ⅲ study[J].{H}OPHTHALMOLOGY,2011.2041-2049. 被引量:1
  • 4Kinge B,Stordahl PB,Forsaa V. Efficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion:results from the sham-controlled ROCC study[J].{H}American Journal of Ophthalmology,2010.310-314. 被引量:1
  • 5Epstein DL,Algvere PV,von Wendt G. Bevacizumab for macular edema in central retinal vein occlusion:a prospective,randomized,double-masked clinical study[J].{H}OPHTHALMOLOGY,2012.1184-1189. 被引量:1
  • 6Brown DM,Heier JS,Clark WL. Intravitreal aflibercept injection in central retinal vein occlusion:1-year results of the phase 3 COPERNICUS study[J].{H}American Journal of Ophthalmology,2013.429-437. 被引量:1
  • 7Korobelnik JF,Holz FG,Roider J. Intravitrial aflibeceept injection for macular edema in central retinal vein occlusion:1-year results of the phase 3 GALILEO study[J].{H}OPHTHALMOLOGY,2013.S0161-S6420. 被引量:1
  • 8我国糖尿病视网膜病变临床诊疗指南(2014年)[J].中华眼科杂志,2014,0(11):851-865. 被引量:1336
  • 9刘新书,张美芬.葡萄膜炎继发黄斑水肿及其药物治疗[J].中华眼科杂志,2015,51(2):151-154. 被引量:14
  • 10黎晓新,白玉婧.关注视网膜静脉阻塞的病因病理对临床实践的指导作用[J].中华眼底病杂志,2018,34(3):205-207. 被引量:22

共引文献63

同被引文献32

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部